Back
Nektar Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
NKTR
Nektar Therapeutics
Last Price:
$77.02
Seasonality Move:
4.06%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.82 | Buy |
| 20-day SMA: | 72.26 | Buy |
| 50-day SMA: | 62.26 | Buy |
| 200-day SMA: | 47.48 | Buy |
| 8-day EMA: | 72.9 | Buy |
| 20-day EMA: | 71.34 | Buy |
| 50-day EMA: | 65.05 | Buy |
| 200-day EMA: | 48.67 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.36 | Buy |
| Relative Strength Index (14 RSI): | 61.17 | Buy |
| Chaikin Money Flow: | 327477 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.13 - 74.41) | Buy |
| Bollinger Bands (100): | (42.28 - 70.02) | Buy |
Nektar Therapeutics Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 76.99 while NKTR 8-day simple moving average is 71.82, which is a Buy signal.
-
The stock price of NKTR is 76.99 while Nektar Therapeutics 20-day SMA is 72.26, which makes it a Buy.
-
Nektar Therapeutics 50-day simple moving average is 62.26 while NKTR share price is 76.99, making it a Buy technically.
-
NKTR stock price is 76.99 and Nektar Therapeutics 200-day simple moving average is 47.48, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Buy
62
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a BuyThe current Nektar Therapeutics [NKTR] share price is $76.99. The Score for NKTR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
1.4B
Price in USD:
76.99
Share Volume:
552.5K
Nektar Therapeutics 52-Week Range
52-Week High:
78.81
52-Week Low:
6.48
Buy
62
Nektar Therapeutics (NKTR)
is a Buy
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 76.99 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is not overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 76.99 while NKTR 8-day exponential moving average is 72.90, which is a Buy signal.
-
The stock price of NKTR is 76.99 while Nektar Therapeutics 20-day EMA is 71.34, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 65.05 while NKTR share price is 76.99, making it a Buy technically.
-
NKTR stock price is 76.99 and Nektar Therapeutics 200-day simple moving average is 48.67, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.63 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $1.23 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is 2.36, suggesting Nektar Therapeutics is a Buy
-
Nektar Therapeutics Relative Strength Index (RSI) is 61.17, which suggest Nektar Therapeutics is overbought
-
The Bollinger Bands (25) for Nektar Therapeutics is (69.13 - 74.41), which suggest Nektar Therapeutics is a Buy
-
The Bollinger Bands (100) for Nektar Therapeutics is (42.28 - 70.02), which suggest Nektar Therapeutics is a Buy
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.